FREE Case Review (866) 588-0600

Roundup Non-Hodgkin Lymphoma

Studies have linked glyphosate, the active ingredient in Roundup weed killer, to an increased risk for a deadly form of cancer known as non-Hodgkin’s lymphoma.

Studies have linked glyphosate, the active ingredient in Monsanto’s Roundup weed killer, to an increased risk for a deadly form of cancer known as non-Hodgkin lymphoma.

Free Confidential Lawsuit Evaluation: If you or a loved one got cancer from Roundup herbicide, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.

Updated: CA Jury Awards Couple $2 Billion in Landmark Roundup Cancer Trial Verdict

May 15, 2019 – Bayer suffered another catastrophic financial hit Monday, the hardest yet involving litigation alleging that its newly adopted Roundup weed killer increases the risk for non-Hodgkin lymphoma and other types of cancer. A jury in the same San Francisco court that served as venue for the previous three roundup trials delivered the bad news, a $2 billion (with a B) fine, the third massive defeat for Bayer in a row.

“Today’s decision by Administrator Wheeler, like virtually every one he and the Trump administration make, completely ignores science in favor of polluters like Bayer,” said Ken Cook, President of the Environmental Working Group (EWG). “This move by EPA should not come as a surprise. Under the control of Trump and Wheeler, the agency is virtually incapable of taking steps to protect people from dangerous chemicals like glyphosate.”

What’s the problem?

A review published by the World Health Organization (WHO) in The Lancet Oncology in May 2015 looked at studies on humans and mice exposed to glyphosate and other popular weed killer. Three human studies were included in the review, all of which appeared to suggest an increased risk for non-Hodgkin lymphoma associated with glyphosate exposure. As a result of these findings, WHO declared that Roundup is “probably carcinogenic to humans.”

The Roundup-Cancer Connection

In April 2014, a review published in the International Journal of Environmental Research and Public Health found that glyphosate exposure was a main reason for the massive increase in non-Hodgkin lymphoma diagnoses over the past three decades. For the review, researchers analyzed 44 studies to see how 80 active ingredients in 21 different chemical classes affected farmers’ risk of developing cancer. They found that exposure to glyphosate doubled a person’s risk of contracting non-Hodgkin lymphoma.

What is Non-Hodgkin Lymphoma

Non-Hodgkin lymphoma, also known as non-Hodgkin lymphoma, is a type of cancer that originates in the lymphatic system, the body’s disease-fighting network. In patients with the disease, tumors develop from lymphocytes – a type of white blood cell.

Non-Hodgkin’s lymphoma is more common than the other general type of lymphoma — Hodgkin lymphoma. Many different subtypes of non-Hodgkin lymphoma exist, including:

Lymphoma Symptoms

Signs and symptoms of non-Hodgkin lymphoma include:

  • Swollen lymph nodes in the neck, armpits or groin
  • Abdominal pain or swelling
  • Chest pain
  • Coughing
  • Trouble breathing
  • Fatigue
  • Fever
  • Night sweats
  • Weight loss

Treatment

According to the American Society of Clinical Oncology (ASCO), there are three main treatments for non-Hodgkin lymphoma: chemotherapy, radiation therapy, and immunotherapy. Occasionally, surgery or stem cell transplantation may be recommended. In some cases a combination of these treatments are utilized.

Remission and the Chance for Recurrence

A remission is when lymphoma cannot be detected in the body and the patient is not experiencing any symptoms. A remission can be temporary or permanent. This uncertainty causes many survivors to feel worried or anxious that the disease will come back. While many remissions are permanent, it’s important to talk with your doctor about the possibility of the cancer returning.

Roundup Cancer Lawsuit Allegations

Roundup lawsuits allege that Monsanto:

  • Failed to adequately research the link between Roundup and cancer;
  • Failed to warn consumers and the medical community about the risks of glyphosate toxicity;
  • Failed to ensure that farmers and other agricultural workers received adequate protection against the side effects of Roundup;
  • Misrepresented the safety of Roundup for decades, and
  • Actively concealed studies linking glyphosate to non-Hodgkin lymphoma and other types of cancer.

Update: EPA Says Roundup Chemical Not Linked to Cancer

May 3, 2019 – Officials with the Environmental Protection Agency (EPA) have gone public denying reports that Roundup can increase the risk for non-Hodgkin lymphoma; is the claim science-based or just another example of Trump’s pro-business agenda at work?

Judge Orders Bayer to Begin Settlement Negotiations with Plaintiffs in Roundup Lawsuits

April 18, 2019 – The judge overseeing the multidistrict litigation (MDL 2741) created to handle lawsuits alleging cancer from Roundup weed killer has instructed Bayer AG to pursue mediation with plaintiffs, asking the company to settle as many of the thousands of cases pending against it before they reach the trial phase. There are currently more than 11,200 lawsuits pending against Bayer AG, which bought out Monsanto last September for $63 billion, and the company has lost 2 straight bellwether trials in a row.

Exposure to Roundup “Most Significant Contributing Factor” in Plaintiffs’ Cancer, Pathologist Says

April 9, 2019 – A pathologist from the City of Hope National Medical Center in Duarte, California, who claims to have poured over more than 2,000 pages of medical records for the plaintiffs in the next Roundup cancer trial concluded that exposure to glyphosate was the “most significant contributing factor” in causing their development of non-Hodgkin lymphoma. Dr. Dennis Weisenburger, who was hired by the plaintiffs and has authored nearly 400 peer-reviewed articles on non-Hodgkin lymphoma, seemed confident in his assertion that Roundup was the likely causative agent in both plaintiffs’ development of the disease.

California Jury Awards Plaintiff $80 Million Settlement in Roundup Cancer Lawsuit

April 1, 2019 – Monsanto has been ordered to pay an $80 million settlement to a San Francisco man who claims that his development of non-Hodgkin lymphoma was the result of his use of Roundup weed killer, in a rare split-trial which could influence the outcome of thousands more cases.

Bayer’s Shares Plummet Following Consecutive Roundup Trial Losses

March 22, 2019 – Shares of Bayer AG dropped over 12% on Wednesday after a jury in federal court in San Francisco ruled for the second time that its Roundup weed killer caused cancer. It was the pharmaceutical giant’s biggest 1-day loss in 16 years, according to Reuters.

San Francisco Jury Rules Plaintiff’s Cancer Caused by Roundup

March 19, 2019 – A jury in California’s Northern District has determined that Monsanto’s controversial Roundup herbicide significantly contributed to a man’s development of non-Hodgkin lymphoma, a deadly cancer that develops from white blood cells called lymphocytes. The jury of 5 women and 1 man reached a unanimous decision in favor of plaintiff Ed Hardeman after deliberating for a week; the verdict marks another costly setback for Bayer AG, which purchased Monsanto last August for about $63 billion.

San Francisco Jury Rules Plaintiff’s Cancer Caused by Roundup

March 19, 2019 – A jury in California’s Northern District has determined that Monsanto’s controversial Roundup herbicide significantly contributed to a man’s development of non-Hodgkin lymphoma, a deadly cancer that develops from white blood cells called lymphocytes. The jury of 5 women and 1 man reached a unanimous decision in favor of plaintiff Ed Hardeman after deliberating for a week; the verdict marks another costly setback for Bayer AG, which purchased Monsanto last August for about $63 billion.

Roundup Lymphoma Lawsuit in the Hands of California Jury

March 13, 2019 – Monsanto Roundup was a major contributor to a California man’s development of non-Hodgkin lymphoma, his attorneys stated during closing arguments on Tuesday in the first bellwether trial over the controversial herbicide, while the defense team argued that the man’s cancer was unique and there was to way to determine what caused it. The suit, filed on behalf of 70-year-old Plaintiff Edward Hardeman, is just the second of more than 11,000 similar complaints brought by people who claim they got cancer from Monsanto Roundup herbicide.

Monsanto Cancer Report Deemed Admissible in Roundup Lawsuit

March 4, 2019 – The prosecution in a Roundup cancer lawsuit currently underway in California will be allowed to use a 1999 internal document from the Monsanto Company which concluded that glyphosate can cause genetic damage to human cells. U.S. District Judge Vince Chhabria said Monsanto’s attorneys “opened the door” to allowing the report by arguing that glyphosate is not genotoxic — meaning that it can’t cause genetic damage to human cells.

Roundup Cancer Trial Moves Forward

July 12, 2018 – Hundreds of lawsuits alleging Roundup caused cancer advanced a crucial step forward on Thursday when a judge in San Francisco Superior Court ruled that a cancer victim could present expert testimony linking the herbicide to non-Hodgkin lymphoma. U.S. District Judge Vince Chhabria said evidence linking glyphosate was “rather weak”; however, he also affirmed that the opinions of 3 experts linking the weed killer to cancer were relevant, and not tantamount to “junk science.”

Do I have a Roundup Lawsuit?

The Product Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Roundup cancer lawsuits. We are handling individual litigation nationwide and currently accepting new lymphoma cases in all 50 states.

Free Drug Lawsuit Evaluation: Again, if you were diagnosed with any form of non-Hodgkin lymphoma after using Roundup, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
Awards & recognition